Corcept Therapeutics (CORT) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.71% |
| Dec 31, 2025 | 2.08% |
| Sep 30, 2025 | 12.88% |
| Jun 30, 2025 | -3.60% |
| Mar 31, 2025 | -32.47% |
| Dec 31, 2024 | 4.40% |
| Sep 30, 2024 | 13.44% |
| Jun 30, 2024 | 10.15% |
| Mar 31, 2024 | 0.28% |
| Dec 31, 2023 | -23.72% |
| Sep 30, 2023 | 3.53% |
| Jun 30, 2023 | 22.73% |
| Mar 31, 2023 | -5.45% |
| Dec 31, 2022 | 6.06% |
| Sep 30, 2022 | 25.16% |
| Jun 30, 2022 | 3.24% |
| Mar 31, 2022 | 30.11% |
| Dec 31, 2021 | 61.49% |
| Sep 30, 2021 | 40.57% |
| Jun 30, 2021 | 94.64% |
| Mar 31, 2021 | 50.51% |
| Dec 31, 2020 | 52.64% |
| Sep 30, 2020 | 102.04% |
| Jun 30, 2020 | 228.80% |
| Mar 31, 2020 | 82.68% |
| Dec 31, 2019 | 105.27% |
| Sep 30, 2019 | 53.11% |
| Jun 30, 2019 | 36.76% |
| Mar 31, 2019 | 32.58% |
| Dec 31, 2018 | 36.72% |
| Sep 30, 2018 | 48.12% |
| Jun 30, 2018 | 29.48% |
| Mar 31, 2018 | 37.80% |
| Dec 31, 2017 | 36.99% |
| Sep 30, 2017 | 25.94% |
| Jun 30, 2017 | 31.55% |
| Mar 31, 2017 | 23.98% |
| Dec 31, 2016 | 22.10% |
| Sep 30, 2016 | 27.27% |
| Jun 30, 2016 | 17.29% |
| Mar 31, 2016 | 19.62% |
| Dec 31, 2015 | 22.57% |
| Sep 30, 2015 | 16.41% |